Concepedia

Pengfei Zhou

PZ

Statistics

Publications

35

Citations

1.9K

H-Index

24

Active since

2002

Affiliations

Wuhan YZY Biopharma (China)(Current)

Huazhong University of Science and Technology

Tongji Hospital

Chongqing Medical University

Stomatological Hospital of Chongqing Medical University

Pengfei Zhou is an author at Wuhan YZY Biopharma (China) specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

2002–2025

35

Publications

35

The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-β and PD-L1

Ming Yi, Jing Zhang, Anping Li et al. · Journal of Hematology & Oncology · 2021 · 239 citations · Full text

Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors

Ming Yi, Mengke Niu, Yuze Wu et al. · Journal of Hematology & Oncology · 2022 · 170 citations · Full text

Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers

Ming Yi, Mengke Niu, Jing Zhang et al. · Journal of Hematology & Oncology · 2021 · 167 citations · Full text

Anti-TGF-β/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer

Ming Yi, Yuze Wu, Mengke Niu et al. · Journal for ImmunoTherapy of Cancer · 2022 · 143 citations · Full text

Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy

Dejun Zhang, Lei Zhao, Pengfei Zhou et al. · Cancer Cell International · 2017 · 106 citations · Full text

1–5 of 35